Gelonghui, April 18 | Lisheng Pharmaceutical (002393.SZ) said on the investor interactive platform that the company holds the drug number for potassium iodide tablets and has a production capacity of more than 10 billion tablets (tablets) per year for oral solid preparations. If the market needs it, the company can organize production at any time to ensure market supply. The indications for potassium iodide tablets produced by the company are: prevention and treatment of endemic goiter, thyroid function, preparation before surgery for hyperthyroidism, and hyperthyroidism crisis. For: prevention and treatment of endemic goiter, thyroid function, preparation before surgery for hyperthyroidism, and hyperthyroidism crisis.
力生制药(002393.SZ)：具备口服固体制剂年产100亿片(粒)以上的生产能力
Lisheng Pharmaceutical (002393.SZ): Has a production capacity of more than 10 billion tablets (tablets) per year for oral solid preparations
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.